Novel DX Funding & Investors
Baltimore, MD
Novel Microdevices is a medical device startup that develops a handheld point-of-care medical device to facilitate molecular diagnostics. Its device uses microfluidics to analyze a raw biological sample directly at the point of care and takes only 30 minutes to interpret quality results that enable healthcare professionals to achieve lab-quality results in a lab-free environment. The company was founded by Andrea Pais in 2014 and is headquartered in Baltimore, Maryland.
noveldx.comTotal Amount Raised: $15,200,000
Novel DX Funding Rounds
Grant
$1,400,000
Grant Investors
National Institutes of Health (NIH)Grant
$13,800,000
Grant Investors
CARB-X
Funding info provided by Diffbot.